Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 364

1.

Clinicopathological factors impact the survival outcome following the resection of combined hepatocellular carcinoma and cholangiocarcinoma.

Yap AQ, Chen CL, Yong CC, Kuo FY, Wang SH, Lin CC, Liu YW, Lin TL, Li WF, Millan CA, Wang CC.

Surg Oncol. 2013 Mar;22(1):55-60. doi: 10.1016/j.suronc.2012.09.003. Epub 2012 Oct 24.

PMID:
23102615
2.

Clinical and pathological features of Allen's type C classification of resected combined hepatocellular and cholangiocarcinoma: a comparative study with hepatocellular carcinoma and cholangiocellular carcinoma.

Tang D, Nagano H, Nakamura M, Wada H, Marubashi S, Miyamoto A, Takeda Y, Umeshita K, Dono K, Monden M.

J Gastrointest Surg. 2006 Jul-Aug;10(7):987-98.

PMID:
16843869
3.

Surgical treatments and prognoses of patients with combined hepatocellular carcinoma and cholangiocarcinoma.

Kim KH, Lee SG, Park EH, Hwang S, Ahn CS, Moon DB, Ha TY, Song GW, Jung DH, Kim KM, Lim YS, Lee HC, Chung YH, Lee YS, Suh DJ.

Ann Surg Oncol. 2009 Mar;16(3):623-9. doi: 10.1245/s10434-008-0278-3. Epub 2009 Jan 6.

PMID:
19130133
4.

Comparison of combined hepatocellular and cholangiocarcinoma with hepatocellular carcinoma and intrahepatic cholangiocarcinoma.

Lee WS, Lee KW, Heo JS, Kim SJ, Choi SH, Kim YI, Joh JW.

Surg Today. 2006;36(10):892-7.

PMID:
16998683
5.

Combined hepatocellular carcinoma and cholangiocarcinoma: clinical features, treatment modalities, and prognosis.

Yin X, Zhang BH, Qiu SJ, Ren ZG, Zhou J, Chen XH, Zhou Y, Fan J.

Ann Surg Oncol. 2012 Sep;19(9):2869-76. doi: 10.1245/s10434-012-2328-0. Epub 2012 Mar 27.

PMID:
22451237
6.

Postresection Outcomes of Combined Hepatocellular Carcinoma-Cholangiocarcinoma, Hepatocellular Carcinoma and Intrahepatic Cholangiocarcinoma.

Yoon YI, Hwang S, Lee YJ, Kim KH, Ahn CS, Moon DB, Ha TY, Song GW, Jung DH, Lee JW, Hong SM, Yu ES, Lee SG.

J Gastrointest Surg. 2016 Feb;20(2):411-20. doi: 10.1007/s11605-015-3045-3. Epub 2015 Dec 1.

PMID:
26628072
7.

Combined hepatocellular and cholangiocarcinoma: a clinicopathologic study of 26 resected cases.

Yano Y, Yamamoto J, Kosuge T, Sakamoto Y, Yamasaki S, Shimada K, Ojima H, Sakamoto M, Takayama T, Makuuchi M.

Jpn J Clin Oncol. 2003 Jun;33(6):283-7.

PMID:
12913082
8.

Histologic factors affecting prognosis following hepatectomy for intrahepatic cholangiocarcinoma.

Uenishi T, Hirohashi K, Kubo S, Yamamoto T, Hamba H, Tanaka H, Kinoshita H.

World J Surg. 2001 Jul;25(7):865-9. Erratum in: World J Surg 2002 Feb;26(2):283.

PMID:
11572025
9.

Hepatitis B virus-related combined hepatocellular-cholangiocarcinoma: clinicopathological and prognostic analysis of 390 cases.

Chu KJ, Lu CD, Dong H, Fu XH, Zhang HW, Yao XP.

Eur J Gastroenterol Hepatol. 2014 Feb;26(2):192-9. doi: 10.1097/MEG.0b013e3283625df9.

PMID:
24370644
10.

Clinicopathological characteristics of 15 patients with combined hepatocellular carcinoma and cholangiocarcinoma.

Zuo HQ, Yan LN, Zeng Y, Yang JY, Luo HZ, Liu JW, Zhou LX.

Hepatobiliary Pancreat Dis Int. 2007 Apr;6(2):161-5.

PMID:
17374575
11.

Complete resection of the caudate lobe of the liver with tumor: technique and experience.

Fan J, Wu ZQ, Tang ZY, Zhou J, Qiu SJ, Ma ZC, Zhou XD, Yu YQ.

Hepatogastroenterology. 2001 May-Jun;48(39):808-11.

PMID:
11462929
12.

Intrahepatic cholangiocarcinoma: prognostic factors after surgical resection.

Guglielmi A, Ruzzenente A, Campagnaro T, Pachera S, Valdegamberi A, Nicoli P, Cappellani A, Malfermoni G, Iacono C.

World J Surg. 2009 Jun;33(6):1247-54. doi: 10.1007/s00268-009-9970-0.

PMID:
19294467
13.

Clinicopathological features and prognosis of combined hepatocellular carcinoma and cholangiocarcinoma after surgery.

Lee SD, Park SJ, Han SS, Kim SH, Kim YK, Lee SA, Ko YH, Hong EK.

Hepatobiliary Pancreat Dis Int. 2014 Dec;13(6):594-601.

PMID:
25475861
14.

Caudate hepatectomy for cancer: a single institution experience with 150 patients.

Hawkins WG, DeMatteo RP, Cohen MS, Jarnagin WR, Fong Y, D'Angelica M, Gonen M, Blumgart LH.

J Am Coll Surg. 2005 Mar;200(3):345-52.

PMID:
15737844
15.

Clinicopathological analysis of 14 patients with combined hepatocellular carcinoma and cholangiocarcinoma.

Yu XH, Xu LB, Zeng H, Zhang R, Wang J, Liu C.

Hepatobiliary Pancreat Dis Int. 2011 Dec;10(6):620-5.

PMID:
22146626
16.

Surgical resection of hilar cholangiocarcinoma: analysis of survival and postoperative complications.

Hasegawa S, Ikai I, Fujii H, Hatano E, Shimahara Y.

World J Surg. 2007 Jun;31(6):1256-63.

PMID:
17453285
17.

Long-term prognosis of combined hepatocellular and cholangiocarcinoma after curative resection comparison with hepatocellular carcinoma and cholangiocarcinoma.

Lee JH, Chung GE, Yu SJ, Hwang SY, Kim JS, Kim HY, Yoon JH, Lee HS, Yi NJ, Suh KS, Lee KU, Jang JJ, Kim YJ.

J Clin Gastroenterol. 2011 Jan;45(1):69-75. doi: 10.1097/MCG.0b013e3181ce5dfa.

PMID:
20142755
18.

Intrahepatic cholangiocarcinoma and combined hepatocellular-cholangiocarcinoma: a Western experience.

Portolani N, Baiocchi GL, Coniglio A, Piardi T, Grazioli L, Benetti A, Ferrari Bravo A, Giulini SM.

Ann Surg Oncol. 2008 Jul;15(7):1880-90. doi: 10.1245/s10434-008-9933-y. Epub 2008 Apr 29.

PMID:
18443881
19.

[Analysis of prognostic factors after curative resection for combined hepatocellular and cholangiocarcinoma].

Kim W, Lee JH, Kim YJ, Yoon JH, Suh KS, Lee KU, Jang JJ, Lee HS.

Korean J Gastroenterol. 2007 Mar;49(3):158-65. Korean.

20.

Surgical treatment of patients with mixed hepatocellular carcinoma and cholangiocarcinoma.

Nakamura S, Suzuki S, Sakaguchi T, Serizawa A, Konno H, Baba S, Baba S, Muro H.

Cancer. 1996 Oct 15;78(8):1671-6.

Supplemental Content

Support Center